Cost Effectiveness Impact Of Oral Fludarabine In Chronic Lymphocytic Leukemia. The French Experience

M. Leporrier, B. Cazin, K. Maloum, X. Lenne, D. Theis, M.C. d'Alche-Gautier, P. Rufat, F. Prunieras, C. Compagne and B. Dervaux
Additional contact information
X. Lenne: LEM - Lille - Economie et Management - Université de Lille, Sciences et Technologies - CNRS - Centre National de la Recherche Scientifique
B. Dervaux: LEM - Lille - Economie et Management - Université de Lille, Sciences et Technologies - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Date: 2005-09
References: Add references at CitEc
Citations:

Published in Communication affichée au XI International Workshop on CLL., Sep 2005, Brooklyn, New-York, United States

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-00226352

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().